Nuvilex, Inc. Phase
Nuvilex, Inc. Phase III Clinical Trials in Strong Hands With Dr. Gerald Crabtree
April 01, 2013 08:30 ET | Nuvilex, Inc.
NEW YORK, NY--(Marketwire - Apr 1, 2013) - Nuvilex, Inc. (OTCQB: NVLX) CEO, Dr. Robert Ryan knew exactly what he was doing two years ago when he announced Dr. Gerald Crabtree would be joining his...
INSCOR, Inc. Announc
INSCOR, Inc. Announces the Addition of Mark Bolt to the Company's Board of Directors
March 28, 2013 09:00 ET | INSCOR, Inc.
LAS VEGAS, NV--(Marketwire - Mar 28, 2013) - INSCOR, Inc. (PINKSHEETS: IOGA) is pleased to announce the addition of Mark T. Bolt to the company's Board of Directors. INSCOR Chief Executive...
INSCOR, Inc. Expande
INSCOR, Inc. Expanded Plan Offers Solutions to High Income Earners, Entertainers and Athletes
March 26, 2013 08:30 ET | INSCOR, Inc.
LAS VEGAS, NV--(Marketwire - Mar 26, 2013) - INSCOR, Inc. (PINKSHEETS: IOGA) announces the release of its new program based on the company's FIT OPEB plan. This new plan is tailored...
Potential Future Sal
Potential Future Sales of Nuvilex, Inc. Cancer Treatments Make Investment in Cell-in-a-Box Worth It
March 26, 2013 08:30 ET | Nuvilex, Inc.
NEW YORK, NY--(Marketwire - Mar 26, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is a small biotechnology company out of Silver Spring, Maryland, but its future might be anything but small. As the company...
INSCOR, Inc. Names N
INSCOR, Inc. Names New CEO and President to Management Team
March 22, 2013 08:30 ET | INSCOR, Inc.
LAS VEGAS, NV--(Marketwire - Mar 22, 2013) - INSCOR, Inc. (PINKSHEETS: IOGA) is pleased to officially announce its top management team. INSCOR has appointed Richard Doerr as the company's new...
Timing Is Right for
Timing Is Right for Big Pharma to Add Nuvilex, Inc. Technology to Its Pipeline
March 21, 2013 08:30 ET | Nuvilex, Inc.
NEW YORK, NY--(Marketwire - Mar 21, 2013) -  Nuvilex, Inc. (OTCQB: NVLX) has close to $30-million invested in its "Cell-in-a-Box" technology, and as the company gets closer to the start of its...
INSCOR, Inc. Develop
INSCOR, Inc. Develops Low-Cost Funding Solution for Government's Trillion Dollar Problem
March 20, 2013 08:30 ET | INSCOR, Inc.
LAS VEGAS, NV--(Marketwire - Mar 20, 2013) - INSCOR, Inc. (PINKSHEETS: IOGA) is pleased to announce it has redesigned its business model to capitalize on the financial opportunities that exist with...
Nuvilex, Inc. Diabet
Nuvilex, Inc. Diabetes Studies Could Eliminate Need for Daily Insulin Requirements
March 18, 2013 08:30 ET | Nuvilex, Inc.
NEW YORK, NY--(Marketwire - Mar 18, 2013) - When investors look into biotechnology and pharmaceutical companies as an investment opportunity, three areas of research stand out as the most favorable...
Nuvilex, Inc. Anothe
Nuvilex, Inc. Another Biotech Changing the Face of Medical Marijuana
March 14, 2013 08:30 ET | Nuvilex, Inc.
NEW YORK, NY--(Marketwire - Mar 14, 2013) - Nuvilex, Inc. (OTCQB: NVLX), an international biotechnology and clinical stage provider of natural products and cell and gene therapy solutions for the...
Nuvilex, Inc. Cell-i
Nuvilex, Inc. Cell-in-a-Box Technology Could Revitalize the Stem Cell Phenomenon
March 12, 2013 08:30 ET | Nuvilex, Inc.
NEW YORK, NY--(Marketwire - Mar 12, 2013) - Nuvilex, Inc. (OTCQB: NVLX), an international biotech company, could dramatically shift the stem cell conversation with its Cell-in-a-Box™...